Motif ID: Foxi1_Foxo1
Z-value: 2.951


Transcription factors associated with Foxi1_Foxo1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Foxi1 | ENSMUSG00000047861.2 | Foxi1 |
Foxo1 | ENSMUSG00000044167.5 | Foxo1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxo1 | mm10_v2_chr3_+_52268337_52268388 | 0.07 | 6.7e-01 | Click! |
Top targets:
Showing 1 to 20 of 200 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 478 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 64.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
3.9 | 62.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
4.8 | 52.9 | GO:0060539 | diaphragm development(GO:0060539) |
8.7 | 52.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
3.5 | 38.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.2 | 33.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.6 | 31.1 | GO:0060013 | righting reflex(GO:0060013) |
2.4 | 31.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
2.4 | 26.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
3.0 | 26.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
2.4 | 26.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.2 | 25.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.8 | 24.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.7 | 24.4 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 24.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
4.5 | 22.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.2 | 21.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 19.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
1.1 | 19.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
3.7 | 18.5 | GO:0015671 | oxygen transport(GO:0015671) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 196 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 154.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 119.1 | GO:0005634 | nucleus(GO:0005634) |
12.5 | 62.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 61.3 | GO:0016607 | nuclear speck(GO:0016607) |
4.0 | 36.0 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 35.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
4.7 | 28.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 26.5 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 26.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
7.7 | 23.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
2.1 | 22.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 22.2 | GO:0005902 | microvillus(GO:0005902) |
0.6 | 21.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.8 | 21.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 20.0 | GO:0000776 | kinetochore(GO:0000776) |
0.3 | 19.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 18.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 18.2 | GO:0005814 | centriole(GO:0005814) |
3.0 | 17.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 14.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 313 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 126.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 70.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
2.4 | 35.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 35.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 34.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 33.0 | GO:0003774 | motor activity(GO:0003774) |
0.9 | 29.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
3.7 | 25.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.8 | 25.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
8.1 | 24.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
7.7 | 23.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.2 | 23.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.3 | 22.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.2 | 21.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 21.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.4 | 19.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 19.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
3.7 | 18.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 18.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 17.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
Gene overrepresentation in C2:CP category:
Showing 1 to 20 of 68 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 70.8 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
1.2 | 63.1 | PID_PLK1_PATHWAY | PLK1 signaling events |
1.2 | 55.7 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.6 | 32.7 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.7 | 30.0 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.6 | 29.9 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
2.0 | 28.4 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 26.0 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.6 | 23.0 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 18.6 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 15.8 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.3 | 14.0 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 11.5 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.2 | 10.1 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 9.9 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 9.3 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 8.8 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.2 | 8.7 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.4 | 8.6 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 8.1 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Showing 1 to 20 of 107 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 93.3 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 58.2 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
2.4 | 40.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.5 | 39.2 | REACTOME_KINESINS | Genes involved in Kinesins |
1.1 | 38.1 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
1.0 | 38.1 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 29.4 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
1.6 | 24.3 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 24.2 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.1 | 23.4 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
2.5 | 22.6 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.4 | 21.2 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 19.0 | REACTOME_PI3K_AKT_ACTIVATION | Genes involved in PI3K/AKT activation |
0.6 | 14.0 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 13.7 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.8 | 12.7 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 12.6 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.7 | 11.7 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 10.8 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.6 | 10.3 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |